BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 27469216)

  • 1. Genomic characterization of high-count MBL cases indicates that early detection of driver mutations and subclonal expansion are predictors of adverse clinical outcome.
    Barrio S; Shanafelt TD; Ojha J; Chaffee KG; Secreto C; Kortüm KM; Pathangey S; Van-Dyke DL; Slager SL; Fonseca R; Kay NE; Braggio E
    Leukemia; 2017 Jan; 31(1):170-176. PubMed ID: 27469216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphoma-like monoclonal B cell lymphocytosis in a patient population: biology, natural evolution, and differences from CLL-like clones.
    Vander Meeren S; Heyrman B; Renmans W; Bakkus M; Maes B; De Raeve H; Schots R; Jochmans K
    Ann Hematol; 2018 Jul; 97(7):1219-1227. PubMed ID: 29492600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined patterns of IGHV repertoire and cytogenetic/molecular alterations in monoclonal B lymphocytosis versus chronic lymphocytic leukemia.
    Henriques A; Rodríguez-Caballero A; Nieto WG; Langerak AW; Criado I; Lécrevisse Q; González M; Pais ML; Paiva A; Almeida J; Orfao A
    PLoS One; 2013; 8(7):e67751. PubMed ID: 23844084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural history of monoclonal B-cell lymphocytosis among relatives in CLL families.
    Slager SL; Lanasa MC; Marti GE; Achenbach SJ; Camp NJ; Abbasi F; Kay NE; Vachon CM; Cerhan JR; Johnston JB; Call TG; Rabe KG; Kleinstern G; Boddicker NJ; Norman AD; Parikh SA; Leis JF; Banerji V; Brander DM; Glenn M; Ferrajoli A; Curtin K; Braggio E; Shanafelt TD; McMaster ML; Weinberg JB; Hanson CA; Caporaso NE
    Blood; 2021 Apr; 137(15):2046-2056. PubMed ID: 33512457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immunoglobulin gene repertoire of low-count chronic lymphocytic leukemia (CLL)-like monoclonal B lymphocytosis is different from CLL: diagnostic implications for clinical monitoring.
    Dagklis A; Fazi C; Sala C; Cantarelli V; Scielzo C; Massacane R; Toniolo D; Caligaris-Cappio F; Stamatopoulos K; Ghia P
    Blood; 2009 Jul; 114(1):26-32. PubMed ID: 19029437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-throughput sequencing for the identification of NOTCH1 mutations in early stage chronic lymphocytic leukaemia: biological and clinical implications.
    Lionetti M; Fabris S; Cutrona G; Agnelli L; Ciardullo C; Matis S; Ciceri G; Colombo M; Maura F; Mosca L; Gentile M; Recchia AG; Ilariucci F; Musolino C; Molica S; Di Raimondo F; Cortelezzi A; Rossi D; Gaidano G; Morabito F; Ferrarini M; Neri A
    Br J Haematol; 2014 Jun; 165(5):629-39. PubMed ID: 24579978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. General population low-count CLL-like MBL persists over time without clinical progression, although carrying the same cytogenetic abnormalities of CLL.
    Fazi C; Scarfò L; Pecciarini L; Cottini F; Dagklis A; Janus A; Talarico A; Scielzo C; Sala C; Toniolo D; Caligaris-Cappio F; Ghia P
    Blood; 2011 Dec; 118(25):6618-25. PubMed ID: 21876118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal B-cell lymphocytosis: a reappraisal of its clinical implications.
    Molica S; Mauro FR; Molica M; Del Giudice I; Foà R
    Leuk Lymphoma; 2012 Sep; 53(9):1660-5. PubMed ID: 22335530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal B-cell lymphocytosis: Does the elderly patient need a specialistic approach?
    Angelillo P; Capasso A; Ghia P; Scarfò L
    Eur J Intern Med; 2018 Dec; 58():2-6. PubMed ID: 30268574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What does it mean I have a monoclonal B-cell lymphocytosis?: Recent insights and new challenges.
    Scarfò L; Ghia P
    Semin Oncol; 2016 Apr; 43(2):201-8. PubMed ID: 27040697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal B cell lymphocytosis.
    Lanasa MC; Allgood SD; Weinberg JB
    Leuk Lymphoma; 2010 Aug; 51(8):1386-8. PubMed ID: 20629528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical aspects of monoclonal B-cell lymphocytosis.
    Mowery YM; Lanasa MC
    Cancer Control; 2012 Jan; 19(1):8-17. PubMed ID: 22143058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-CLL-like monoclonal B-cell lymphocytosis in the general population: prevalence and phenotypic/genetic characteristics.
    Nieto WG; Teodosio C; López A; Rodríguez-Caballero A; Romero A; Bárcena P; Gutierrez ML; Langerak AW; Fernandez-Navarro P; Orfao A; Almeida J;
    Cytometry B Clin Cytom; 2010; 78 Suppl 1():S24-34. PubMed ID: 20839335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different biology and clinical outcome according to the absolute numbers of clonal B-cells in monoclonal B-cell lymphocytosis (MBL).
    Rawstron AC; Shanafelt T; Lanasa MC; Landgren O; Hanson C; Orfao A; Hillmen P; Ghia P
    Cytometry B Clin Cytom; 2010; 78 Suppl 1(Suppl 1):S19-23. PubMed ID: 20839333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly similar genomic landscapes in monoclonal B-cell lymphocytosis and ultra-stable chronic lymphocytic leukemia with low frequency of driver mutations.
    Agathangelidis A; Ljungström V; Scarfò L; Fazi C; Gounari M; Pandzic T; Sutton LA; Stamatopoulos K; Tonon G; Rosenquist R; Ghia P
    Haematologica; 2018 May; 103(5):865-873. PubMed ID: 29449433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia.
    Nadeu F; Delgado J; Royo C; Baumann T; Stankovic T; Pinyol M; Jares P; Navarro A; Martín-García D; Beà S; Salaverria I; Oldreive C; Aymerich M; Suárez-Cisneros H; Rozman M; Villamor N; Colomer D; López-Guillermo A; González M; Alcoceba M; Terol MJ; Colado E; Puente XS; López-Otín C; Enjuanes A; Campo E
    Blood; 2016 Apr; 127(17):2122-30. PubMed ID: 26837699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical presentation, progression, and outcome of patients with clonal B-cell counts of less than 5 × 10(9)/l, 5 to 10 × 10(9)/l, and more than 10 × 10(9)/l and chronic lymphocytic leukemia immunophenotype.
    Foster AE; Nguyen TT; Al-Hammadi N; Frater JL; Hassan A; Kreisel F
    Am J Clin Pathol; 2015 Jan; 143(1):70-7. PubMed ID: 25511144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor mutational load is prognostic for progression to therapy among high-count monoclonal B-cell lymphocytosis.
    Kleinstern G; Boddicker NJ; O'Brien DR; Allmer C; Rabe KG; Norman AD; Griffin R; Yan H; Ma T; Call TG; Bruins L; Brown S; Bonolo de Campos C; Hanson CA; Leis JF; Ding W; Vachon CM; Kay NE; Oakes CC; Parker AS; Brander DM; Weinberg JB; Furman RR; Shanafelt TD; Cerhan JR; Parikh SA; Braggio E; Slager SL
    Blood Adv; 2024 May; 8(9):2118-2129. PubMed ID: 38359367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal B-cell lymphocytosis.
    Maitre E; Troussard X
    Best Pract Res Clin Haematol; 2019 Sep; 32(3):229-238. PubMed ID: 31585623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic lymphocytic leukemia-like monoclonal B-cell lymphocytosis exhibits an increased inflammatory signature that is reduced in early-stage chronic lymphocytic leukemia.
    Blanco G; Puiggros A; Sherry B; Nonell L; Calvo X; Puigdecanet E; Chiu PY; Kieso Y; Ferrer G; Palacios F; Arnal M; Rodríguez-Rivera M; Gimeno E; Abella E; Rai KR; Abrisqueta P; Bosch F; Calon A; Ferrer A; Chiorazzi N; Espinet B
    Exp Hematol; 2021 Mar; 95():68-80. PubMed ID: 33421548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.